Key clinical point: Lifestyle change remains powerful cardiovascular preventive medicine.
Major finding: For each of six lifestyle risk factors at target after a first MI, the risks of all-cause and cardiovascular mortality decreased in linear stepwise fashion.
Study details: This case-control study included more than 65,000 Swedish patients followed for up to 12 years after their first acute MI, as well as 325,000 matched controls.
Disclosures: The SWEDEHEART study analysis was funded free of commercial support. The presenter reported serving as a consultant to or receiving speakers’ fees from Amgen, AstraZeneca, Bayer, Novo Nordisk, and Sanofi.
Hagstrom E. ESC 2019, Abstract 5117.